The UK is now facing a significant problem in how it secures the country’s medicines’ supply chain after leaving the EU on 1 January 2021. But rather than view this as an insurmountable problem, FarmaTrust is calling on the UK government to be true to its word and deliver new Brexit benefits.
Research has shown that solar cells made from lead halide perovskite are just as good at converting sunlight into energy as commercial silicon-based solar cells. However, their instability in humidity and heat has hampered their large-scale roll-out. Read more in C&I Magazine.
Covid-19 was an unpredictable so-called black swan event in 2020 and the second wave in Europe indicates we might need to live with the pandemic for a long time. Although the development of vaccines is a breakthrough, the impact of vaccination will be slow to materialise.
Advanced materials highlights in C&I Magazine Issue 2, 2021 by Arno Kraft, Heriot-Watt University, Edinburgh, UK.
Gene editing tool CRISPR-Cas9 has been used to track metastasis in mice implanted with thousands of modified human cancer cells. The technology enabled the creation of a map of cell divisions visualised using coloured phylogenetic trees, where each colour represents a different location in the body. Read the article in C&I Magazine.
Applied chemistry highlight by Nigel P Freestone, University of Northampton, UK for February 2021.
Photodetectors to detect long wavelength infrared (LWIR) are highly sought after for applications in earth science and astronomy, remote sensing, night vision, optical communication, and thermal and medical imaging. Read the article in C&I magazine.
A two-pronged antibiotic strategy has shown promise against difficult-to-treat bacteria. Researchers at The Wistar Institute in Philadelphia targeted an enzyme IspH used by bacteria to make isoprenoids, essential for cell walls and energy production
Adding a portion of mushrooms to the diet increased intake of important micronutrients, including vitamin D, a new study has shown (Food Sci. Nutrition, doi: 10.1002/fsn3.2120 ). Read the article in C&I magazine.
Microfluidic technologies are rapidly becoming the method of choice for micro- and nanoparticle production across a number of sectors, from cell biology research to drug development. This approach offers a number of advantages over traditional batch methods, including precise process control, enhanced reliability, and the ability to easily scale up production. Read more in C&I Magazine.